中华老年心脑血管病杂志

[1]Hata A.Functions of microRNAs in cardiovascular biology and disease[J].Annu Rev Physiol,2013,75:69-93.DOI:10.1146/annurev-physiol-030212-183737.

[2]Quiat D,Olson EN.MicroRNAs in cardiovascular disease:from pathogenesis to prevention and treatment[J].J Clin Invest,2013,123(1):11-18.DOI:10.1172/JCI62876.

[3]Lindahl B.Acute coronary syndrome-the present and future role of biomarkers[J].Clin Chem Lab Med,2013,51(9):1699-1706.DOI:10.1515/cclm-2013-0074.

[4]Thum T,Condorelli G.Long noncoding RNAs and micro RNAs in cardiovascular pathophysiology[J].Circ Res,2015,116(4):751-762.DOI:10.1161/CIRCRESAHA.116.303549.

[5]Xu J,Zhao J,Evan G,et al.Circulating microRNAs:novel biomarkers for cardiovascular diseases[J].J Mol Med(Berl),2012,90(8):865-875.DOI:10.1007/s00109-011-0840-5.

[6]Li C,Pei F,Zhu X,et al.Circulating microRNAs as novel and sensitive biomarkers of acute myocardial infarction[J].Clin Biochem,2012,45(10-11):727-732.DOI:10.1016/j.clinbiochem.2012.04.013.

[7]Wang F,Chen C,Wang D.Circulating microRNAs in cardiovascular diseases:from biomarkers to therapeutic targets[J].Front Med,2014,8(4):404-418.DOI:10.1007/s11684-014-0379-2.

[8]Schober A,Weber C.Mechanisms of microRNAs in atherosclerosis[J].Annu Rev Pathol,2016,11:583-616.DOI:10.1146/annurev-pathol-012615-044135.

[9]Jeong HS,Kim JY,Lee SH,et al.Synergy of circulating miR-212with markers for cardiovascular risks to enhance estimation of atherosclerosis presence[J].PLoS One,2017,12(5):e177809.DOI:10.1371/journal.pone.0177809.

[10]Li Y,Yang C,Zhang L,et al.MicroRNA-210induces endothelial cell apoptosis by directly targeting PDK1in the setting of atherosclerosis[J].Cell Mol Biol Lett,2017,22:3.DOI:10.1186/s11658-017-0033-5.

[11]Xin Y,Yang C,Han Z.Circulating miR-499as a potential biomarker for acute myocardial infarction[J].Ann Transl Med,2016,4(7):135.DOI:10.21037/atm.2016.03.40.

[12]Shalaby SM,El-Shal AS,Shoukry A,et al.Serum miRNA-499and miRNA-210:apotential role in early diagnosis of acute coronary syndrome[J].IUBMB Life,2016,68(8):673-682.DOI:10.1002/iub.1529.

[13]Zhang L,Chen X,Su T,et al.Circulating miR-499are novel and sensitive biomarker of acute myocardial infarction[J].J Thorac Dis,2015,7(3):303-308.DOI:10.3978/j.issn.2072-1439.2015.02.05.

[14]Liu X,Fan Z,Zhao T,et al.Plasma miR-1,miR-208,miR-499as potential predictive biomarkers for acute myocardial infarction:an independent study of Han population[J].Exp Gerontol,2015,72:230-238.DOI:10.1016/j.exger.2015.10.011.

[15]Nishimura Y,Kondo C,Morikawa Y,et al.Plasma miR-208as a useful biomarker for drug-induced cardiotoxicity in rats[J].J Appl Toxicol,2015,35(2):173-180.DOI:10.1002/jat.3044.

[16]Han Z,Zhang L,Yuan L,et al.Change of plasma microRNA-208level in acute myocardial infarction patients and its clinical significance[J].Ann Transl Med,2015,3(20):307.DOI:10.3978/j.issn.2305-5839.2015.10.25.

[17]Li LM,Cai WB,Ye Q,et al.Comparison of plasma micro RNA-1and cardiac troponin T in early diagnosis of patients with acute myocardial infarction[J].World J Emerg Med,2014,5(3):182-186.DOI:10.5847/wjem.j.1920-8642.2014.03.004.

[18]Ponikowski P,Voors AA,Anker SD,et al.2016ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC),developed with the special contribution of the Heart Failure Association(HFA)of the ESC[J].Eur J Heart Fail,2016,18(8):891-975.DOI:10.1002/ejhf.592.

[19]Lai KB,Sanderson JE,Izzat MB,et al.Micro-RNA and mRNA myocardial tissue expression in biopsy specimen from patients with heart failure[J].Int J Cardiol,2015,199:79-83.DOI:10.1016/j.ijcard.2015.07.043.

[20]Kuosmanen SM,Hartikainen J,Hippelinen M,et al.Micro RNA profiling of pericardial fluid samples from patients with heart failure[J].PLoS One,2015,10(3):e119646.DOI:10.1371/journal.pone.0119646.

[21]Endo K,Naito Y,Ji X,et al.MicroRNA 210as a biomarker for congestive heart failure[J].Biol Pharm Bull,2013,36(1):48-54.DOI:10.1248/bpb.b12-00578.

[22]Su M,Wang J,Wang C,et al.MicroRNA-221inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis[J].Cell Death Differ,2015,22(6):986-999.DOI:10.1038/cdd.2014.187.

[23]Batkai S,Thum T.MicroRNAs in hypertension:mechanisms and therapeutic targets[J].Curr Hypertens Rep,2012,14(1):79-87.DOI:10.1007/s11906-011-0235-6.

[24]Kontaraki JE,Marketou ME,Zacharis EA,et al.Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells:novel targets in essential hypertension[J].J Hum Hypertens,2014,28(8):510-516.DOI:10.1038/jhh.2013.117.

[25]Deiuliis J,Mihai G,Zhang J,et al.Renin-sensitive microRNAs correlate with atherosclerosis plaque progression[J].J Hum Hypertens,2014,28(4):251-258.DOI:10.1038/jhh.2013.97.

[26]Kontaraki JE,Marketou ME,Zacharis EA,et al.MicroRNA-9and microRNA-126expression levels in patients with essential hypertension:potential markers of target-organ damage[J].J Am Soc Hypertens,2014,8(6):368-375.DOI:10.1016/j.jash.2014.03.324.

[27]Santulli G,Iaccarino G,De Luca N,et al.Atrial fibrillation and microRNAs[J].Front Physiol,2014,5:15.DOI:10.3389/fphys.2014.00015.

[28]McManus DD,Lin H,Tanriverdi K,et al.Relations between circulating microRNAs and atrial fibrillation:data from the Framingham Offspring Study[J].Heart Rhythm,2014,11(4):663-669.DOI:10.1016/j.hrthm.2014.01.018.

[29]Wang J,Wang Y,Han J,et al.Integrated analysis of micro RNA and mRNA expression profiles in the left atrium of patients with nonvalvular paroxysmal atrial fibrillation:role of miR-146b-5p in atrial fibrosis[J].Heart Rhythm,2015,12(5):1018-1026.DOI:10.1016/j.hrthm.2015.01.026.